Kawasaki Disease: Clinical Trials

56 trials for Kawasaki Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 12 unknown, 11 recruiting, 4 not yet recruiting. 11 Phase 2, 10 Phase 3, 6 Not applicable, 5 Phase 4, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 5, Unknown 2, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1
Phase 310Completed 5, Recruiting 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Not applicable6Unknown 3, Recruiting 2, Completed 1
Phase 45Completed 2, Recruiting 2, Not yet recruiting 1
Phase 14Completed 4
Early Phase 11Completed 1

Follow Kawasaki Disease: new trials by email Literature Review of Kawasaki Disease trials Research Report on Kawasaki Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
IVIG, Aspirin, Firsekibart - Kawasaki Disease
Phase 2 / Phase 3Not yet recruitingChildren's Hospital of Fudan University902026-11-012026-10-22
Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities
atorvastatin of dose level 1, atorvastatin of dose level 2, atorvastatin of dose level 3 - Kawasaki Disease, Coronary Artery Abnormalities
Phase 3RecruitingChildren's Hospital of Fudan University92026-06-082026-06-16
Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki Disease
AI-Based Early Warning System for Kawasaki Disease - Kawasaki Disease, Chest X-ray for Clinical Evaluation
Not yet recruitingXinhua Hospital, Shanghai Jiao Tong University School of Medicine200002026-02-012026-02-12
MASKd: a Study on Kawasaki Disease (KD) Complicated by Macrophage Activation Syndrome (MAS)
Kawasaki Disease, Macrophage Activation Syndrome (MAS)
Not yet recruitingMeyer Children's Hospital IRCCS1502026-02-012026-03-25
Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
Rivaroxaban Oral Tablet [Xarelto], Aspirin or Clopidogrel, Warfarin - Kawasaki Disease, Coronary Artery Aneurysm
Phase 4RecruitingChildren's Hospital of Fudan University1002025-06-012026-07-06
Cardiovascular Risk in Children With Chronic Conditions Study
Kidney Transplant, Familial Hypercholesterolaemia
RecruitingSemmelweis University3002025-04-012025-08-08
Non Inferiority KawasakI Trial With Anakinra
Anakinra, Intravenous Immunoglobulins, Human - Kawasaki Disease, Anakinra
Phase 4Not yet recruitingMeyer Children's Hospital IRCCS382025-04-012024-11-21
Kawasaki MATCH Trial
Kawasaki MATCH - Kawasaki Disease
Not applicableRecruitingUniversity of California, San Diego2002025-03-012025-12-18
Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular Disease
Kawasaki Disease, Cardiovascular Disease
Enrolling by invitationWest China Second University Hospital2402024-09-012024-10-15
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
Rivaroxaban (Xarelto) - Kawasaki Disease, Pilot Study
Phase 4RecruitingChildren's Hospital of Fudan University102024-01-102026-10-22
A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
ANAKINRA, Intravenous immunoglobulin - Kawasaki Disease
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris842023-10-202024-02-28
The Value of Cardiovascular Imaging in Kawasaki Disease
Kawasaki Disease
Enrolling by invitationWest China Second University Hospital5002023-09-012024-10-15
Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart Diseases
study of biological samples and echocardiographic data and link with need of hemodynamic support - Myocarditis, Pediatric Inflammatory Multisystem Syndrome
UnknownCentral Hospital, Nancy, France1002023-09-012023-08-30
A Blood Test to Diagnose Kawasaki Disease
Kawasaki Disease
UnknownHBI Solutions Inc.8002023-07-012023-03-23
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
Kawasaki Disease, Coronary Artery Aneurysm
RecruitingChildren's Hospital of Fudan University602023-01-012025-05-29
Clinical Precise Diagnosis and Treatment in the Kawasaki Disease
Echocardiography, Genomics NGS sequencing - Kawasaki Disease
UnknownAffiliated Hospital of Nantong University8002021-08-012023-08-01
European and North Indian Cohort of KaWasaki dIsease
Kawasaki Disease
RecruitingMeyer Children's Hospital IRCCS1032021-07-132025-09-29
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
sample collection - SARS CoV-2, Kawasaki Disease
Not applicableRecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1202021-06-102025-01-15
Defibrotide in Children With High Risk Kawasaki Disease
Defibrotide - Kawasaki Disease
Phase 2UnknownNew York Medical College22021-02-242023-10-26
Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease
IVIG, Aspirin, Infliximab - Kawasaki Disease
Phase 3WithdrawnChildren's Hospital of Fudan University2020-10-012021-03-12

Showing 20 of 56. Sign in to see all of them.

Narrower conditions

Mucocutaneous Lymph Node Syndrome (56)  ·  Coronary Aneurysm (7)  ·  Hypertension (2)  ·  pediatric multisystem inflammatory disease, COVID-19 related (2)  ·  3-Methylglutaconic Aciduria, Type V (1)  ·  Achalasia Addisonianism Alacrimia syndrome (1)  ·  Acrodysostosis (1)  ·  Addison Disease (1)  ·  Adrenal Insufficiency (1)  ·  Alagille Syndrome (1)  ·  Alstrom Syndrome (1)  ·  Amnesia, Transient Global (1)  ·  Aniridia (1)  ·  Aniridia and Absent Patella (1)  ·  Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation (1)

Broader conditions

Hemic and Lymphatic Diseases (56)  ·  Lymphatic Diseases (56)  ·  Skin Diseases (56)  ·  Skin Diseases, Vascular (56)  ·  Skin and Connective Tissue Diseases (56)  ·  Vascular Diseases (56)  ·  Cardiovascular Diseases (55)  ·  Vasculitis (55)  ·  Heart Diseases (11)  ·  Aneurysm (7)  ·  Coronary Disease (7)  ·  Myocardial Ischemia (7)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)

Interventions

Immunoglobulins, Intravenous (10)  ·  Aspirin (8)  ·  Infliximab (6)  ·  Interleukin 1 Receptor Antagonist Protein (6)  ·  Atorvastatin (3)  ·  Immunoglobulin G (2)  ·  Prednisolone (2)  ·  Rivaroxaban (2)  ·  Technetium Tc 99m Sestamibi (2)  ·  canakinumab (2)  ·  Abatacept (1)  ·  Albuterol (1)  ·  Aminocaproic Acid (1)  ·  Amiodarone (1)  ·  Appendectomy (1)

Sponsors

Children's Hospital of Fudan University (10)  ·  University of California, San Diego (7)  ·  National Taiwan University Hospital (4)  ·  Meyer Children's Hospital IRCCS (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Chang Gung Memorial Hospital (2)  ·  Green Cross Corporation (2)  ·  Hospices Civils de Lyon (2)  ·  Lantheus Medical Imaging (2)  ·  West China Second University Hospital (2)  ·  Affiliated Hospital of Nantong University (1)  ·  Central Hospital, Nancy, France (1)  ·  Duke University (1)  ·  Fudan University (1)  ·  HBI Solutions Inc. (1)

Countries

United States (16)  ·  China (15)  ·  Taiwan (7)  ·  France (6)  ·  Canada (4)  ·  Italy (4)  ·  South Korea (3)  ·  Brazil (2)  ·  Thailand (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Chile (1)  ·  Croatia (1)  ·  Hungary (1)  ·  India (1)

Top investigators

Fang Liu, MD (5)  ·  Ho-Chang Kuo, MD, PhD (2)  ·  Jane C Burns, M.D. (2)  ·  Jane C Burns, MD (2)  ·  Adriana H Tremoulet, MD (1)  ·  Adriana H. Tremoulet, M.D. (1)  ·  Adriana Tremoulet, MD (1)  ·  Amanda M. Terry, MA (1)  ·  Andras Bratincsak, MD PhD (1)  ·  Andrea Taddio, MD (1)  ·  Arturo Borzutzky, MD (1)  ·  Chen Chu, MD (1)  ·  Chi Hornik (1)  ·  Ernest Kuchar, Professor (1)  ·  Fang Liu, MD. (1)

Results publications

PMID 16362893, PMID 22173935, PMID 22446961, PMID 23305955, PMID 23901839, PMID 24495555, PMID 24572997, PMID 25205598, PMID 25858045, PMID 26372452, PMID 27080929, PMID 27923814, PMID 29313803, PMID 29933749, PMID 31048415, PMID 32779863, PMID 33600060, PMID 34895290, PMID 35545881, PMID 39040184, PMID 40178858, PMID 41809203, PMID 41985133

NIH funding

2014 (1), R01HL140898 (1)